RareBoost Semineri: Dr. Öğr. Üyesi Birol Tibet, MD, PhD “Designing Research with Impact: Integrating Early HTA and HEOR into Preclinical Innovation”

Seminer Özeti (İngilizce)

In a global research ecosystem where public funding is competitive and innovation lifecycles are accelerating, scientific merit alone is no longer enough.

To attract funding, earn adoption, and generate measurable health and policy impact, today’s researchers must design studies that go beyond discovery — and into real-world relevance.

This high-level seminar led by Asst. Prof. Birol Tibet will introduce participants to the emerging global paradigm that links preclinical research with Health Technology Assessment (HTA) and Health Economics and Outcomes Research (HEOR) — not at the end of the pipeline, but at the earliest stages of R&D.

With international experience at the crossroads of academic research, health policy, and innovation funding, Dr. Tibet will offer a deep yet practical roadmap for embedding “value thinking” early in the design of new therapies, diagnostics, and biotechnologies.

Through clear frameworks, real-world case examples, and tools like Horizon Scanning, Target Product Profile (TPP), early economic modeling, and multi-criteria value frameworks, this session will demonstrate how IBG researchers can future-proof their projects for both fundability and adoption — without compromising scientific integrity.

Konuşmacı Hakkında

Dr. Birol Tibet, MD, PhD; tıp, sağlık ekonomisi ve sağlık politikası alanlarında güçlü bir disiplinlerarası geçmişe sahip bir hekim, araştırmacı ve halk sağlığı akademisyenidir. Dr. Tibet, Bahçeşehir Üniversitesi Sağlık Teknolojileri Değerlendirme Merkezi’nin (BAU-HTA) kuruluş sürecine liderlik etmekte olup, Bahçeşehir Üniversitesi Tıp Fakültesi Halk Sağlığı Anabilim Dalı’nda Doktor Öğretim Üyesi olarak görev yapmaktadır.